Structural Neuroimaging Markers of Cognitive Decline in Parkinson’s Disease
Cognitive impairment in patients with Parkinson’s disease is a major challenge since it has been established that 25 to 40% of patients will develop cognitive impairment early in the disease. Furthermore, it has been reported that up to 80% of Parkinsonian patients will eventually develop dementia....
Saved in:
| Main Authors: | Alexandru Hanganu, Oury Monchi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2016-01-01
|
| Series: | Parkinson's Disease |
| Online Access: | http://dx.doi.org/10.1155/2016/3217960 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Recent Advances in Neuroimaging Methods
by: Oury Monchi, et al.
Published: (2008-01-01) -
Olfactory dysfunction and amyloid-positivity in Parkinson’s disease—longitudinal analysis of cognitive decline and cerebrospinal fluid markers
by: Victoria Larsson, et al.
Published: (2025-01-01) -
The Parkinson’s Disease Progression Neuroimaging Initiative
by: Shiyi Zhu, et al.
Published: (2021-01-01) -
Multi-Parametric Cerebellar Neuroimaging in Subjective Cognitive Decline as Predictors of Cognitive Alterations in Alzheimer’s Spectrum
by: Shailendra Mohan Tripathi, et al.
Published: (2025-06-01) -
A prospective study of cognitive impairment in Parkinson’s disease: clinical, neuropsychological, and neuroimaging correlates
by: Ahmed A. Gaballa, et al.
Published: (2025-06-01)